NEW YORK, November 29, 2017 /PRNewswire/ --
According to ArcviewMarket Research, the regulated cannabis sales in North American totaled $6.7 billion in 2016 and are expected to grow at a compound annual growth rate of 25 percent to an estimated $20.2 billion
According to another report from Arcview Market Research, the licensed cannabis stores are as profitable as Starbucks stores and the adult-use markets will double the size of the medical market by 2021. Arcview CEO, Troy Dayton, "This report shows that retail cannabis could be as big as the iPhone. It's clearer than ever that there is a pot of gold at the end of the rainbow for those investors and operators who are willing to deal with the uncertainties and difficulties of current regulations."
Global Payout, Inc. (OTC: GOHE) announced yesterday that, "its majority owned subsidiary, MoneyTrac Technology, Inc. ("MTRAC", the "Company") has established a key strategic partnership with T&T Financial to shore-up and bolster the sales and marketing related services that MTRAC is delivering to many of the underserved businesses in the emerging cannabis industry.
Over the past several weeks, MTRAC has been working in collaboration with additional partners in the financial services sector to lay the groundwork for the banking solutions they intend to offer retailers and suppliers who are operating fully compliant businesses in cannabis. This newly executed partnership with T&T Financial will provide MTRAC with critical sales and marketing support for the banking services and solutions they will be offering to an industry that is currently in dire need of an effective and practical solution to support the massive amount of commerce that currently exists within it.
It is MTRAC's intent to position itself to launch their banking services as soon as possible as it recognizes the need for it amongst businesses will be stronger than ever in 2018 as cannabis becomes recreational in one of the nation's largest economic states, California. And as the Company moves forward with this objective, they will look to establish additional partnerships with companies, such as T&T Financial, whose existing services and solutions can be leveraged by MTRAC to develop and offer the most powerful and effective banking solution available in the industry.
T&T Financial is a full service financial services company located in Anaheim, CA, servicing the needs of business and institutional clients. The principals have a combined 40 years of experience and the firm approaches all solutions with a dynamic approach that the world constantly changes just as its tools and products should adapt to the needs."
Easton Pharmaceuticals, Inc. (OTC: EAPH) is a diversified specialty pharmaceutical company involved in various pharmaceutical sectors and other growing industries. Recently, the company announced it is days away from its first equipment delivery to commence operations on its aggregate business with partner 1124123 Ontario Limited following its final payment which completed its $1.3 Million CDN JV agreement towards a 50% property ownership interest and various businesses including a lucrative aggregate business and the cultivation of medical / recreational marijuana for national Canadian market. Acquires construction quotes towards the building of a facility towards medical / recreational marijuana for Canadian market.
Lexaria Bioscience Corp. (OTCQB: LXRP) has multiple patents pending in over 40 countries around the world and was granted its first patents in the USA and in Australia related to edible forms of cannabinoids. On November 9, 2017, the company announced it has filed a new patent application with the US Patent and Trademark Office utilizing the Lexaria DehydraTECH[TM] technology for delivery of phosphodiesterase type 5 (PDE5) inhibitors - trade names of existing well-known products include Viagra[TM] (sildenafil) and Cialis[TM] (tadalafil). In its new patent application, Lexaria has named the PDE5 inhibitors from the group consisting of avanafil, lodenafil, mirodenafil, sildenafil (or analogs thereof, for example, actetildenafil, hydroxyacetildenafil, or dimethylsildenafil), tadalafil, vardenafil, udenafil, acetildenafil, and thiomethisosildenafil. In addition, under the new patent application each of these named molecules may be combined with a cannabinoid such as cannabidiol ("CBD"), where the cannabinoid delivered in concert may provide complementary vasodilatory activity beneficial together with the PDE5 inhibitor GB Sciences, Inc. (OTCQB: GBLX) is a diverse cannabis company, focused on standardized cultivation and production methods; as well as biopharmaceutical research and development. On October 23, 2017, the company projected sales of $500,000 in October and continued sales of at least $500,000 per month over the next three months. GB Sciences recorded unaudited sales of approximately $320,000 in the three months ended 9/30/17. The company is operating at 200 grow lights, which is only 30% of its expected final capacity after build out is completed. After the final build out, cultivation revenues will continue to increase with a target flower capacity of $18Million annually. The company is expected to open its production facility in late November or early December of 2017. This operating unit should generate additional significant free cash flow from oil over 2018 at a steadily accelerating pace. CV Sciences, Inc. (OTCQB: CVSI) operates two distinct business segments: a drug development division focused on developing and commercializing novel therapeutics utilizing synthetic CBD; and, a consumer product division focused on manufacturing, marketing and selling plant-based CBD products to a range of market sectors. On November 14, 2017, the company announced it has been named on Deloitte's Technology Fast 500™, an annual ranking of the fastest growing companies in the technology, media, telecommunications, life sciences and energy tech sectors in North America. The Deloitte Technology Fast 500 is based on percentage of revenue growth from fiscal year 2013 to 2016, with CV Sciences growing by 403% during this period. 2017 marks CV Sciences' first year named on the Deloitte's Technology Fast 500™ list. Overall, 2017 Technology Fast 500™ companies achieved revenue growth ranging from 135% to 59,093% from 2013 to 2016, with median growth of 380%.
Subscribe Now! Watch us report from NYSE https://www.youtube.com/FinancialBuzzMedia
Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz
Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz
Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/
FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.
For further information: [email protected] +1-877-601-1879
Subscribe to our Free Newsletters!
Strokes occur when blood flow to an area of the brain is cut off. It is imperitive to detect the ...
Bile duct cancer occurs either within the liver or the point where the bile ducts emerge from the ...
Xeroderma pigmentosum is a rare inherited condition marked by extreme sensitivity to sunlight and ...View All